Results 281 to 290 of about 501,389 (308)

Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials

Lancet, The, 2013
Antoinette Moran, Linda A Dimeglio, Stephen E Gitelman   +2 more
exaly  

Immunosuppression through inhibition of interleukin-2/interleukin-2 receptor interaction

Transplantation Proceedings, 1999
openaire   +2 more sources

Induction therapy with the selective interleukin-23 inhibitor risankizumab in patients with moderate-to-severe Crohn's disease: a randomised, double-blind, placebo-controlled phase 2 study

Lancet, The, 2017
B G Feagan, Julian Panes, Arthur Kaser
exaly  

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies

Lancet, The, 2012
Daniel F Freitag, John Gregson, Peter Willeit   +2 more
exaly  

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

Lancet, The, 2012
Daniel I Swerdlow, Michael V Holmes, Karoline B Kuchenbaecker   +2 more
exaly  

Interleukin-21: a double-edged sword with therapeutic potential

Nature Reviews Drug Discovery, 2014
Warren J Leonard, Rosanne Spolski
exaly  

Interleukin-2 receptor

2011
openaire   +1 more source

Interleukin-2 receptor

2006
openaire   +1 more source

The interleukin-2 receptor

1997
Mark A. Goldsmith, Warner C. Greene
openaire   +1 more source

Tumour necrosis factor α and interleukin 1β in relapse of Crohn's disease

Lancet, The, 1999
Jochen Hampe
exaly